TARGETED ANTI-CANCER THERAPY USING RITUXIMAB, A CHIMAERIC ANTI-CD20 ANTIBODY (IDEC-C2B8) IN THE TREATMENT OF NON-HODGKIN'S B-CELL LYMPHOMA
作者： D. R. Anderson , A. Grillo-López , C. Varns , K. S. Chambers , N. Hanna
DOI: 10.1042/BST0250705
关键词:
摘要:
portlandpress.com
biochemsoctrans.org参考文章(0)